Earnings

Tango Therapeutics Q4 FY25 Earnings Results

Financial Performance and Profitability Tango Therapeutics reported zero collaboration revenue for the fourth quarter of 2025, a decrease from $5.4…

Burlington Stores Q4 FY25 Earnings Results

Revenue Performance Burlington Stores delivered solid top-line expansion in the fourth quarter of fiscal 2025, with total sales increasing 11%…

CorMedix (CRMD) reports higher Q4 2025 net profit on strong revenue growth

CorMedix (CRMD) reports higher Q4 2025 net profit on strong revenue growth

Biopharmaceutical company CorMedix Inc. (NASDAQ: CRMD) reported a sharp increase in revenues for the fourth quarter of fiscal 2025, primarily…

Bilibili (BILI) Q4 FY25 profit surges amid advertising growth and cost control

Bilibili Inc. (NASDAQ: BILI) on Thursday reported a sharp increase in fourth-quarter profit, driven by strong advertising growth and strict…

Victoria’s Secret Q4 2025 Earnings Results

Victoria’s Secret & Co. reported fourth quarter and full year fiscal 2025 results, delivering stronger than expected sales and earnings…

Liquidia Corporation (LQDA) swings to profit in Q4 FY25 on strong revenue growth

Biopharmaceutical company Liquidia Corporation (NASDAQ: LQDA) reported a profit for the fourth quarter of fiscal 2025, compared to a loss…

Burlington Stores Q4 2025 Earnings Results

Burlington Stores reported financial results for the fourth quarter and full fiscal year 2025, delivering stronger than expected earnings and…

Ciena Q1 2026 Earnings Results

Ciena reported financial results for the first quarter of fiscal 2026, delivering a strong revenue increase and an earnings beat…

Broadcom (AVGO) reports higher Q1 FY26 revenue and profit; results beat estimates

Semiconductor company Broadcom, Inc. (NASDAQ: AVGO) on Wednesday said its first-quarter fiscal 2026 revenues and adjusted earnings increased year-over-year. The…

Earnings Summary: EyePoint (EYPT) Q4 2025 net loss widens

EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results…